Mezagitamab
Product Specifications
CAS Number
2227490-52-8
Target
Apoptosis, CD38
Related Pathways
Immunology/Inflammation, Apoptosis
Purity
0.991
Bioactivity
Mezagitamab (TAK-079) is a fully humanized IgG1λ monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells), which depletes CD38-expressing tumor cells through antibody- and complement-dependent cytotoxicity Mezagitamab may be used in the study of recurrent/refractory multiple myeloma (RRMM), which is the most common form of cancer. multiple myeloma (RRMM) and primary thrombocytopenic purpura (ITP) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036176-HRP 200 µL
GOT1, CT (GOT1, Aspartate aminotransferase, cytoplasmic, Glutamate oxaloacetate transaminase 1, Transaminase A) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
orb1670229-01 48 Tests
Mouse Epinephrine/Adrenaline (EPI) ELISA Kit
Sign In for Pricing
View Details orb1670229-02 96 Tests
Mouse Epinephrine/Adrenaline (EPI) ELISA Kit
Sign In for Pricing
View Details 